Kecellitics Biotech Company Ltd Report issue

Government Phase 1 Phase 2

Organization Overview

First Clinical Trial
2019
NCT04100187
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Kecellitics Biotech Company Ltd